Khiron Life Sciences (Khiron Life Sciences) Scaled Net Operating Assets : 0.66 (As of Sep. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Khiron Life Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Khiron Life Sciences's operating assets for the quarter that ended in Sep. 2022 was $27.37 Mil. Khiron Life Sciences's operating liabilities for the quarter that ended in Sep. 2022 was $6.59 Mil. Khiron Life Sciences's Total Assets for the quarter that ended in Jun. 2022 was $31.43 Mil. Therefore, Khiron Life Sciences's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2022 was 0.66.

Khiron Life Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Khiron Life Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Scaled Net Operating Assets Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Scaled Net Operating Assets

Get a 7-Day Free Trial

-4.37

965.86

0.93

0.56

0.36

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.67	0.40	0.65	0.62	0.66

Competitive Comparison of Khiron Life Sciences's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Khiron Life Sciences's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Khiron Life Sciences's Scaled Net Operating Assets falls into.

Khiron Life Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Khiron Life Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2021 )
=	(Operating Assets (A: Dec. 2021 )	-	Operating Liabilities (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2020 )
=	(26.056	-	5.248)	/	57.131
=	0.36

where

	Operating Assets		(A: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	33.027	-	6.971
=	26.056

	Operating Liabilities		(A: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6.988	-	0.551	-	1.189
=	5.248

Khiron Life Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2022 )
=	(Operating Assets (Q: Sep. 2022 )	-	Operating Liabilities (Q: Sep. 2022 ))	/	Total Assets (Q: Jun. 2022 )
=	(27.374	-	6.586)	/	31.427
=	0.66

where

	Operating Assets		(Q: Sep. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	28.827	-	1.453
=	27.374

	Operating Liabilities		(Q: Sep. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8.508	-	1.003	-	0.919
=	6.586

Khiron Life Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRNF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.